bf/NASDAQ:CVT_icon.png

COM:CVENT

National Comprehensive Cancer Network (NCCN)

  • Stock

Last Close

8.52

14/06 20:00

Market Cap

4.19B

Beta: -

Volume Today

12.22M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
305.50K
-
154K
49.59%
459K
198.05%
average payables
4.98M
-
3.38M
32.25%
2.41M
28.59%
average receivables
142.91M
-
126.68M
11.36%
116.31M
8.19%
book value per share
2.57
-
2.43
5.25%
3.87
59.16%
3.33
13.90%
capex per share
-0.10
-
-0.13
33.25%
-0.09
34.27%
-0.11
22.41%
-0.12
10.57%
capex to depreciation
-0.45
-
-0.50
12.05%
-0.31
38.55%
-0.34
11.38%
-0.45
29.50%
capex to operating cash flow
-0.98
-
-1.35
38.09%
-1.47
8.49%
-0.37
74.51%
-0.47
24.98%
capex to revenue
-0.10
-
-0.11
12.69%
-0.09
25.19%
-0.09
2.88%
-0.09
4.46%
cash per share
0.15
-
0.14
10.96%
0.30
122.65%
0.29
4.02%
days of inventory on hand
0.70
-
0.42
39.31%
0.20
53.74%
1.20
511.19%
days payables outstanding
10.15
-
8.45
16.76%
5.10
39.61%
3.16
38.00%
days sales outstanding
93.06
-
103.28
10.99%
78.97
23.54%
69.67
11.78%
debt to assets
0.34
-
0.36
4.94%
0.13
62.83%
0.11
20.17%
debt to equity
0.67
-
0.71
5.62%
0.19
73.59%
0.15
20.65%
dividend yield
earnings yield
-0.01
-
-0.02
69.80%
-0.02
20.10%
-0.03
64.34%
-0.04
53.49%
enterprise value
5.57B
-
6.26B
12.41%
3.61B
42.23%
2.75B
23.98%
enterprise value over ebitda
70.26
-
58.25
17.10%
40.21
30.97%
50.61
25.87%
ev to operating cash flow
115.90
-
215.03
85.54%
29.58
86.24%
22.14
25.17%
ev to sales
9.81
-
12.55
27.94%
6.97
44.47%
4.36
37.45%
free cash flow per share
0.00
-
-0.04
1,671.67%
-0.03
19.63%
0.18
745.84%
0.14
24.71%
free cash flow yield
0.00
-
-0.00
1,671.67%
-0.00
29.62%
0.02
1,002.76%
0.03
13.91%
graham net net
-2.14
-
-2.06
3.66%
-1.11
46.22%
-0.88
20.58%
graham number
3.32
-
3.09
7.02%
4.22
36.79%
3.95
6.54%
income quality
-0.92
-
-0.52
43.17%
-0.35
33.60%
-1.42
308.49%
-1.24
12.79%
intangibles to total assets
0
-
0.85
Infinity%
0.86
0.80%
0.84
1.62%
0.83
1.26%
interest coverage
-0.58
-
-1.04
78.80%
-0.86
17.22%
-1.47
70.65%
-7.68
421.98%
interest debt per share
1.82
-
1.80
1.34%
0.79
55.84%
0.51
35.06%
inventory turnover
521.82
-
859.76
64.76%
1.86K
116.19%
304.12
83.64%
invested capital
0.67
-
0.71
5.62%
0.19
73.59%
0.15
20.65%
market cap
4.81B
-
4.81B
0%
5.49B
14.20%
3.44B
37.44%
2.61B
24.11%
net current asset value
-956.09M
-
-919.80M
3.79%
-391.44M
57.44%
-349.35M
10.75%
net debt to ebitda
9.53
-
7.10
25.51%
1.98
72.14%
2.57
30.01%
net income per share
-0.11
-
-0.19
69.80%
-0.17
8.75%
-0.20
17.57%
-0.21
1.45%
operating cash flow per share
0.10
-
0.10
3.50%
0.06
39.41%
0.29
380.25%
0.26
11.53%
payables turnover
35.98
-
43.22
20.14%
71.57
65.59%
115.44
61.30%
receivables turnover
3.92
-
3.53
9.90%
4.62
30.78%
5.24
13.35%
research and ddevelopement to revenue
0.16
-
0.17
3.50%
0.18
4.16%
0.19
5.71%
0.21
11.22%
return on tangible assets
-0.25
-
-0.25
0.28%
-0.24
5.35%
-0.27
10.94%
revenue per share
1.00
-
1.18
18.25%
1.04
12.14%
1.23
18.98%
1.31
5.85%
roe
-0.07
-
-0.07
3.69%
-0.05
26.13%
-0.06
17.83%
roic
-0.02
-
-0.02
25.15%
-0.02
43.21%
-0.05
92.75%
sales general and administrative to revenue
0.16
-
0.16
2.18%
0.16
0.35%
0.17
5.24%
0.16
4.35%
shareholders equity per share
2.57
-
2.43
5.25%
3.87
59.16%
3.33
13.90%
stock based compensation to revenue
0.04
-
0.03
11.08%
0.04
6.94%
0.05
36.11%
0.10
113.70%
tangible asset value
-847.03M
-
-831.22M
1.87%
-318.65M
61.67%
-279.19M
12.38%
tangible book value per share
-1.76
-
-1.73
1.87%
-0.76
56.16%
-0.58
23.69%
working capital
-129.57M
-
-103.34M
20.24%
-73.43M
28.95%
-96.01M
30.75%

All numbers in (except ratios and percentages)